Noninvasive prenatal genetic testing (NIPT) is an advance in the detection of fetal
chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant …

Background Non-invasive prenatal testing (NIPT) can be used to accurately detect fetal
chromosomal anomalies early in pregnancy by assessing cell-free fetal DNA present in …

This paper contains a joint ESHG/ASHG position document with recommendations
regarding responsible innovation in prenatal screening with non-invasive prenatal testing …

Purpose: Prenatal screening for Down syndrome has improved, but the number of resulting
invasive diagnostic procedures remains problematic. Measurement of circulating cell-free …

Purpose To consider the impact and cost-effectiveness of offering preventive population
genomic screening to all young adults in a single-payer health-care system. Methods We …

Thus far, the focus of personalized medicine has been the prevention and treatment of
conditions that affect adults. Although advances in genetic technology have been applied …

Purpose: To compare the preferences of women and health professionals for key attributes
of noninvasive prenatal diagnosis for Down syndrome relative to current invasive tests …

Objective To investigate pregnant women's level of future interest in noninvasive prenatal
diagnosis (NIPD) and what factors might affect expected uptake of this testing. Method …

Noninvasive prenatal genetic testing (NIPT) for chromosomal aneuploidy involving the
analysis of cell-free fetal DNA became commercially available in 2011. The low false …

In the debate surrounding the introduction of non-invasive prenatal testing (NIPT) in prenatal
screening programmes, the concept of routinisation is often used to refer to concerns and …